The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 FMD medicines recall for Beconase Aqueous Nasal Spray and a class 2 pharmacy level recall for Gliclazide 40 mg Tablets.
Glaxo Wellcome UK Ltd T/A GSK is recalling the Beconase Aqueous Nasal Spray with batch number K84X, due to an issue related to error in the decommissioning.
This is the first falsified medicine directive (FMD) recall since July 2019.
“Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED’,” the MHRA statement read.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| K84X | 09-2021 | 1 | 06-Jan-2020 |
Accord UK is recalling all unexpired stock of Gliclazide 40 mg Tablets in Northstar Livery with batch number GU50 from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability testing.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| GU50 | Dec 2020 | 28 | 24/05/2019 |
Pharmacists are asked to stop supplying both products immediately, quarantine remaining stock and return it to the supplier using the approved process.
The government agency also issued a class 4 pharmacy level caution in use for 13 batches of Atrolak (Quetiapine) prolonged release tablets by Accord, as the Patient Information Leaflet (PIL) within the packs are missing the side effects identified from post-marketing experience.
Pharmacists are adviced to ensure that patients are of any missing information and issue the current PILs with special warnings and precautions while dispensing the product.
Atrolak XL 50mg prolonged release tablets PL 20075/0213
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 322729 | 05/2021 | 60 | 19 December 2019 |
| Y06455 | 10/2021 | 60 | 03 September 2019 |
Atrolak XL 150mg prolonged release tablets PL 20075/0446
| Batch Number | Expiry Date | Pack Size | First Distributed |
| Y04771 | 10/2021 | 60 | 06 November 2019 |
| Y04788 | 10/2021 | 60 | 27 September 2019 |
| Y02374 | 05/2021 | 60 | 07 August 2019 |
Atrolak XL 200mg prolonged release tablets PL 20075/0214
| Batch Number | Expiry Date | Pack Size | First Distributed |
| X17653 | 02/2021 | 60 | 24 November 2019 |
| Y06710 | 08/2021 | 60 | 18 November 2019 |
Atrolak XL 300mg prolonged release tablets PL 20075/0215
| Batch Number | Expiry Date | Pack Size | First Distributed |
| Y06909 | 09/2021 | 60 | 04 October 2019 |
| X21602 | 05/2021 | 60 | 07 April 2019 |
| X19649 | 03/2021 | 60 | 03 July 2019 |
| X19866 | 03/2021 | 60 | 11 June 2019 |
Atrolak XL 400mg prolonged release tablets PL 20075/0216
| Batch Number | Expiry Date | Pack Size | First Distributed |
| X21825 | 05/2021 | 60 | 10 October 2019 |
| X18765 | 03/2021 | 60 | 05 July 2019 |
![Potential Side Effects of Mounjaro [What You Need to Know]](https://www.pharmacy.biz/media-library/image.jpg?id=54516976&width=1245&height=700&quality=90&coordinates=0%2C29%2C0%2C29)
